Search For "onasemnogene abeparvovec"
UAE approves gene replacement therapy for new age group in spinal muscular
Updated : 5 months ago IST
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) in eligible adults and children aged two years and above.
Read More